LiveOne is a wrist-worn, cuff-free solution that gives real-time measurements for better care and management of people with hypertension and cardiovascular disorders
Medical wearable technology firm LiveMetric has launched LiveOne, a nano-sensor technology for monitoring blood pressure every 10 seconds.
LiveOne, which received 510(k) clearance from the US Food and Drug Administration (FDA), is a wrist-worn, cuff-free solution that gives real-time measurements for better care and management of people with hypertension and cardiovascular disorders.
According to the firm, the LiveOne wearable is the world’s first MEMS nano-sensor-based, CE and FDA-cleared device with medical accuracy highly correlated to the arterial line.
The device constantly takes the pressure waveform from the radial artery and requires no external calibration.
The LiveOne monitoring service will be made available through health systems, health insurers, and self-insured companies for people with high blood pressure and cardiovascular disease.
LiveMetric vice president Kelly Benning said: “The LiveOne device is intended to combat the worldwide epidemic of hypertension by offering patients and providers meaningful, deeply personalised health information so action can be taken in real-time.
“With the same ease as wearing a watch, the LiveOne device will change how hypertension and cardiovascular disease are managed and treated by offering people a thorough understanding of how their lifestyle, behaviour, and medication impact their blood pressure.
“We are focused on bringing this to millions of users across the channels of our customer base.”
LiveMetric offers a critically required monitoring solution to better assess and monitor people from anywhere and at any time.
The LiveOne band gives an extensive volume of data points both day and night to the clinicians and caregivers to assess patterns and the likelihood of major events.